David Pinto

Dr. David Pinto


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 August 2015 in Annals of Oncology
Verified
Journal Article
Closed access
PDF file
BSBerta Sousa
Berta Sousa
JFJ. Furlanetto
J. Furlanetto
MHM. Hutka
M. Hutka
PGP. Gouveia
P. Gouveia
RWR. Wuerstlein
R. Wuerstlein
FCF. Cardoso
F. Cardoso
This guideline applies to central venous access in adult cancer patients, which includes peripherally inserted central catheters (PICCs), tunnelled central catheters and totally implantable devices. Since most evidence comes from the use of central venous catheters (CVCs) in patients with a diversity of pathologies, some recommendations are based on guidelines and studies which may lack some specificity for cancer patients.

29 March 2021 in Cancers
Verified
Journal Article
Open access
PDF file
Maggie Banys-PaluchowskiMaggie Banys-Paluchowski
Maggie Banys-Paluchowski
MGMaria Luisa Gasparri
Maria Luisa Gasparri
JBJana de Boniface
Jana de Boniface
Oreste D. GentiliniOreste D. Gentilini
Oreste D. Gentilini
ESElmar Stickeler
Elmar Stickeler
TGthe AXSANA Study Group
the AXSANA Study Group
In the last two decades, surgical methods for axillary staging in breast cancer patients have become less extensive, and full axillary lymph node dissection (ALND) is confined to selected patients. In initially node-positive patients undergoing neoadjuvant chemotherapy, however, the optimal management remains unclear. Current guidelines vary widely, endorsing different strategies. We performed a literature review on axillary staging strategies and their place in international recommendations. This overview defines knowledge gaps associated with specific procedures, summarizes currently ongoing clinical trials that address these unsolved issues, and provides the rationale for further research. While some guidelines have already implemented surgical de-escalation, replacing ALND with, e.g., sentinel lymph node biopsy (SLNB) or targeted axillary dissection (TAD) in cN+ patients converting to clinical node negativity, others recommend ALND. Numerous techniques are in use for tagging lymph node metastasis, but many questions regarding the marking technique, i.e., the optimal time for marker placement and the number of marked nodes, remain unanswered. The optimal number of SLNs to be excised also remains a matter of debate. Data on oncological safety and quality of life following different staging procedures are lacking. These results provide the rationale for the multinational prospective cohort study AXSANA initiated by EUBREAST, which started enrollment in June 2020 and aims at recruiting 3000 patients in 20 countries (NCT04373655; Funded by AGO-B, Claudia von Schilling Foundation for Breast Cancer Research, AWOgyn, EndoMag, Mammotome, and MeritMedical).

22 March 2015 in Current Treatment Options in Oncology
Verified
Journal Article
Closed access
PDF file
DRD. Ribnikar
D. Ribnikar
JRJ. M. Ribeiro
J. M. Ribeiro
DPDavid Pinto
David Pinto
BSBerta Sousa
Berta Sousa
APA. C. Pinto
A. C. Pinto
FCF. Cardoso
F. Cardoso

1 April 2021 in The Breast
Verified
Journal Article
Open access
PGPedro F. Gouveia
Pedro F. Gouveia
JCJoana Costa
Joana Costa
PMPedro Morgado
Pedro Morgado
RKRonald Kates
Ronald Kates
DPDavid Pinto
David Pinto
MCMaria João Cardoso
Maria João Cardoso
Innovations in 3D spatial technology and augmented reality imaging driven by digital high-tech industrial science have accelerated experimental advances in breast cancer imaging and the development of medical procedures aimed to reduce invasiveness. A 57-year-old post-menopausal woman presented with screen-detected left-sided breast cancer. After undergoing all staging and pre-operative studies the patient was proposed for conservative breast surgery with tumor localization. During surgery, an experimental digital and non-invasive intra-operative localization method with augmented reality was compared with the standard pre-operative localization with carbon tattooing (institutional protocol). The breast surgeon wearing an augmented reality headset (Hololens) was able to visualize the tumor location projection inside the patient's left breast in the usual supine position. This work describes, to our knowledge, the first experimental test with a digital non-invasive method for intra-operative breast cancer localization using augmented reality to guide breast conservative surgery. In this case, a successful overlap of the previous standard pre-operative marks with carbon tattooing and tumor visualization inside the patient's breast with augmented reality was obtained. Breast cancer conservative guided surgery with augmented reality can pave the way for a digital non-invasive method for intra-operative tumor localization.

1 April 2020 in The Breast
Verified
Journal Article
Open access
CMCarlos Mavioso
Carlos Mavioso
RARicardo J. Araújo
Ricardo J. Araújo
HOHelder Oliveira
Helder Oliveira
JAJoão C. Anacleto
João C. Anacleto
MVMaria Antónia Vasconcelos
Maria Antónia Vasconcelos
MCMaria João Cardoso
Maria João Cardoso
The deep inferior epigastric perforator (DIEP) is the most commonly used free flap in mastectomy reconstruction. Preoperative imaging techniques are routinely used to detect location, diameter and course of perforators, with direct intervention from the imaging team, who subsequently draw a chart that will help surgeons choosing the best vascular support for the reconstruction. In this work, the feasibility of using a computer software to support the preoperative planning of 40 patients proposed for breast reconstruction with a DIEP flap is evaluated for the first time. Blood vessel centreline extraction and local characterization algorithms are applied to identify perforators and compared with the manual mapping, aiming to reduce the time spent by the imaging team, as well as the inherent subjectivity to the task. Comparing with the measures taken during surgery, the software calibre estimates were worse for vessels smaller than 1.5 mm (P = 6e-4) but better for the remaining ones (P = 2e-3). Regarding vessel location, the vertical component of the software output was significantly different from the manual measure (P = 0.02), nonetheless that was irrelevant during surgery as errors in the order of 2-3 mm do not have impact in the dissection step. Our trials support that a reduction of the time spent is achievable using the automatic tool (about 2 h/case). The introduction of artificial intelligence in clinical practice intends to simplify the work of health professionals and to provide better outcomes to patients. This pilot study paves the way for a success story.

8 February 2023 in Breast Care
Verified
Journal Article
Closed access
PDF file
PGPedro Filipe Pereira Gouveia
Pedro Filipe Pereira Gouveia
RLRogélio Luna
Rogélio Luna
FFFrancisco Fontes
Francisco Fontes
DPDavid Pinto
David Pinto
CMCarlos Mavioso
Carlos Mavioso
MCMaria João Cardoso
Maria João Cardoso
Introduction: Augmented reality (AR) has demonstrated a potentially wide range of benefits and educational applications in the virtual health ecosystem. The concept of real-time data acquisition, machine learning-aided processing, and visualization is a foreseen ambition to leverage AR applications in the healthcare sector. This breakthrough with immersive technologies like AR, mixed reality, virtual reality, or extended reality will hopefully initiate a new surgical era: that of the use of the so-called surgical metaverse. Methods: This paper focuses on the future use of AR in breast surgery education describing two potential applications (surgical remote telementoring and impalpable breast cancer localization using AR), along with the technical needs to make it possible. Conclusion: Surgical telementoring and impalpable tumors noninvasive localization are two examples that can have success in the future provided the improvements in both data transformation and infrastructures are capable to overcome the current challenges and limitations.